Metraipolis › archive › dc_e187ad19bfb8
State of pneumococcal vaccine immunity — Europe PMC PMID:38567485
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38567485
- DOI
- 10.1080/21645515.2024.2336358
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T20:05:44.573Z
- SHA-256 of the archived text
f0d49a98488dc6eb141aba59c87af15eff2ac862072d897eb3a7fd09f5c44ab4- Stable URL of this page
https://metraipolis.com/documento/dc_e187ad19bfb8
How to cite
State of pneumococcal vaccine immunity — Europe PMC PMID:38567485 — Europe PMC (en), https://europepmc.org/article/MED/38567485 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_e187ad19bfb8 (Metraipolis archive dc_e187ad19bfb8, sha256 f0d49a98488dc6eb141aba59c87af15eff2ac862072d897eb3a7fd09f5c44ab4)
BibTeX
@misc{dce187ad19bfb8,
title = {State of pneumococcal vaccine immunity — Europe PMC PMID:38567485},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38567485},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_e187ad19bfb8; sha256 f0d49a98488dc6eb141aba59c87af15eff2ac862072d897eb3a7fd09f5c44ab4},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38567485. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Like the other invasive encapsulated bacteria, Streptococcus pneumoniae is also covered with a polysaccharide structure. Infants and elderly are most vulnerable to the invasive and noninvasive diseases caused by S. pneumoniae . Although antibodies against polysaccharide capsule are efficient in eliminating S. pneumoniae , the T cell independent nature of the immune response against polysaccharide vaccines renders them weakly antigenic. The introduction of protein conjugated capsular polysaccharide vaccines helped overcome the weak immunogenicity of pneumococcal polysaccharides and decreased the incidence of pneumococcal diseases, especially in pediatric population. Conjugate vaccines elicit T cell dependent response which involve the interaction of specialized CD4+ T cells, called follicular helper T cells (Tfh) with germinal center B cells in secondary lymphoid organs. Despite their improved immunogenicity, conjugate vaccines still need to be administered three to four times in infants during the first 15 month of their life because they mount poor Tfh response. Recent studies revealed fundamental differences in the generation of Tfh cells between neonates and adults. As the portfolio of pneumococcal conjugate vaccines continues to increase, better understanding of the mechanisms of antibody development in different age groups will help in the development of pneumococcal vaccines tailored for different ages. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Human vaccines & immunotherapeutics, 2024 (prima pubblicazione 2024-04-03). Identificativi: PMID 38567485 · PMCID PMC10993918 · DOI 10.1080/21645515.2024.2336358. Parole chiave degli autori: neonates; TACI; Pneumococcal Vaccines; Tfh Cells. Descrittori MeSH principali: Pneumococcal Infections; Pneumococcal Vaccines. Pagina: https://europepmc.org/article/MED/38567485 — https://doi.org/10.1080/21645515.2024.2336358. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T18:30:56.360Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.